Go Deep
Kohjin Bio Co., Ltd.
Kohjin Bio Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 25,943 | 31.5 | 0.67 | 0.31 | 472.79 |
Kohjin Bio Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Jun 2025 |
|---|---|---|
| EPS | -8.2 | 16.1 |
Kohjin Bio Co., Ltd. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 4,939,025,000.0 | 5,206,287,000.0 | 4,770,096,000.0 | 4,742,992,000.0 | — |
| Net Profit | 251,019,000.0 | 794,759,000.0 | 384,978,000.0 | 829,790,000.0 | — |
| EPS | 49.1 | 157.6 | 92.4 | 199.2 | — |
Kohjin Bio Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 8,904,397,000.0 | 9,066,648,000.0 | 6,589,322,000.0 | 6,134,824,000.0 | — |
| Total Liabilities | 2,959,219,000.0 | 3,284,828,000.0 | 3,246,930,000.0 | 3,116,994,000.0 | — |
| Total Equity | 5,945,178,000.0 | 5,781,820,000.0 | 3,342,392,000.0 | 3,017,830,000.0 | — |
Kohjin Bio Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 27.9%Receivables 6.3%Inventory 9.8%Fixed assets (tangible) 42.7%Long-term investments 7.4%Other assets 5.7%
How it's funded — Mar 2026
Short-term debt 18.5%Long-term debt 2.5%Payables 1.3%Other liabilities 10.9%Shareholders' equity 66.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,486.2 | 3,149.3 | 1,726.9 | 1,462.6 |
| Receivables | 562.4 | 775.1 | 685.3 | 609.5 |
| Inventory | 871.8 | 880.7 | 683.0 | 1,102.6 |
| Fixed assets (tangible) | 3,798.2 | 3,253.7 | 2,586.8 | 2,171.6 |
| Intangible assets | 18.9 | 27.3 | 3.0 | 4.4 |
| Long-term investments | 661.0 | 581.3 | 481.9 | 409.6 |
| Other assets | 505.8 | 399.4 | 422.4 | 374.6 |
| Liabilities & equity | ||||
| Short-term debt | 1,650.0 | 1,650.0 | 1,650.0 | 2,064.8 |
| Long-term debt | 225.0 | 375.0 | 525.0 | 0.0 |
| Payables | 117.0 | 134.1 | 163.5 | 146.3 |
| Other liabilities | 967.2 | 1,125.7 | 908.5 | 905.9 |
| Shareholders' equity | 5,945.2 | 5,781.8 | 3,342.4 | 3,017.8 |
| Net tangible assets | 5,926.3 | 5,754.6 | 3,339.4 | 3,013.5 |
Kohjin Bio Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 698,508,000.0 | 915,551,000.0 | 823,681,000.0 | 461,153,000.0 | — |
| Investing Activities | -867,672,000.0 | -1,090,901,000.0 | -577,354,000.0 | -575,459,000.0 | — |
| Financing Activities | -320,756,000.0 | 1,376,032,000.0 | -1,348,000.0 | -172,209,000.0 | — |